The NP/PA Factor: Why Advanced Practice Providers Are Essential for Life Sciences in 2025
The healthcare landscape is changing and so should the way life sciences engage with providers. Nurse practitioners (NPs) and physician associates (PAs) are no longer secondary players; they’re frontline prescribers managing chronic conditions, initiating therapies, and ensuring adherence for millions of patients. With over 685,000 active NPs and PAs in the U.S., this group now writes nearly 41% of all prescriptions and sees almost half of all patients. Ignoring them means overlooking a critical driver of treatment decisions and patient outcomes.
Despite their growing influence, many life sciences brands still rely on outdated physician-first models. NPs and PAs engage differently than physicians, seeking peer-led education, digital-first resources, and evidence-based insights that directly enhance clinical decision-making. To remain competitive, pharma marketers must adapt strategies that align with how these providers learn, connect, and practice every day.
Our fact sheet, The NP/PA Factor: Why Advanced Practice Providers Are Essential for Life Sciences in 2025, reveals why NPs and PAs represent one of the fastest growing and most impactful prescriber segments in the U.S. You’ll uncover data-driven insights on their prescribing power, preferred engagement channels, and how brands can close the current engagement gap. Download the fact sheet to ensure your strategy connects with the providers who are shaping patient care now and in the future.
